Brains and superior algorithm, for the benefits of patients
Genomic privacy protection guaranteed
Highly accurate and reliable NGS data analysis
Standardisation of the Clinical NGS Dry Lab for higher quality and accuracy of routine NGS-based clinical diagnostics.
Integrated bioinformatic analysis, quality assurance, visualisation and banking of patient NGS data.
Superior algorithm with specific analysis pipelines for each combination of sample type, gene panel, DNA amplification or capture kit and sequencing platform.
Fully validated, automated analysis pipelines for both commercial and proprietary custom panels of genes on any NGS platform. CE/IVD marked analysis pipelines when appropriate.
A proven methodology to optimise, validate the analytical performance and put in production robust bioinformatic pipelines for usage in routine diagnostics.
Privately hosted IT Infrastructure. Commitment to constantly provide processing power and storage capacity under a strict Service Level Agreement.
A single efficient workflow covering all activities of the Clinical NGS Dry Lab through the use of dropGen, a secured web Application provided in SaaS mode (Software as a Service).
Sophia Genetics, the European leader in Data-Driven Medicine, has raised $13.75M in Series B financing in a round led by Dr Mike Lynch’s Invoke Capital, Endeavour Vision and Swisscom.
Investment aims to accelerate European adoption of clinical analytics for genetic diseases.
Sophia Genetics is a pioneer in Data-Driven Medicine, a crossover field that requires deep expertise in Next Generation Sequencing (NGS), combined with highly accurate and scalable predictive algorithms to diagnose genetic diseases. With this investment, Sophia gains access to Invoke’s portfolio company Genalys, whose Cambridge-based mathematicians apply big data approaches to genomic information. The combination means that clinicians and hospitals across Europe gain access to very accurate clinical analytics service for early diagnosis and optimized treatment of cancer and genetic diseases.see more